Application of radiofrequency ablation for the treatment of intermediate-stage hepatocellular carcinoma
Author:
Affiliation:
1. Department of Gastroenterology; Okayama City Hospital; Okayama Japan
2. Department of Gastroenterology and Hepatology; Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science; Okayama Japan
Funder
Grant-in-Aids for Scientific Research
Publisher
Wiley
Subject
Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.13586/fullpdf
Reference23 articles.
1. Epidemiology of viral hepatitis and hepatocellular carcinoma;El-Serag;Gastroenterology,2012
2. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma;J. Hepatol.,2012
3. Management of hepatocellular carcinoma: an update;Bruix;Hepatology,2011
4. Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines);Kokudo;Hepatol. Res.: the official journal of the Japan Society of Hepatology.,2015
5. JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan;Kudo;Liver cancer.,2014
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Long-term outcome and eligibility of radiofrequency ablation for hepatocellular carcinoma over 3.0 cm in diameter;Scientific Reports;2023-09-28
2. Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada;Cancer Treatment Reviews;2023-04
3. Overall survival and toxicity of hepatocellular carcinoma Barcelona Clinic Liver Cancer B patients receiving Y90 radioembolization: analysis of the radiation-emitting SIR-spheres in non-resectable liver tumor (RESiN) registry;Journal of Gastrointestinal Oncology;2023-04
4. Recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: Analysis of the pattern and risk factors;Frontiers in Oncology;2023-02-23
5. Trial Designs for Integrating Novel Therapeutics into the Management of Intermediate-Stage Hepatocellular Carcinoma;Journal of Hepatocellular Carcinoma;2022-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3